Colgate-Palmolive Co (CHIX:CPAd)
€ 78.22 (0%) Market Cap: 61.30 Bil Enterprise Value: 67.71 Bil PE Ratio: 25.08 PB Ratio: 198.19 GF Score: 82/100

Q4 2024 Colgate-Palmolive Co Earnings Call Transcript

Jan 31, 2025 / 01:30PM GMT
Release Date Price: €83.56

Key Points

Positve
  • Colgate-Palmolive Co (CL) achieved net sales of $20 billion in 2024, surpassing their strategic plan ambition a year early.
  • The company delivered high single-digit organic growth for the second consecutive year, with volume growth in every division and category.
  • Increased advertising spending by 15% in 2024, following a 19% increase in 2023, has significantly improved brand health.
  • Colgate-Palmolive Co (CL) achieved gross and operating margin expansion despite foreign exchange headwinds and increased spending.
  • Record operating cash flow and free cash flow, along with record cash returned to shareholders, highlight strong financial performance.
Negative
  • Foreign exchange headwinds negatively impacted net sales and gross margin, posing a challenge to earnings growth.
  • The company faced softness in some parts of Europe and continued challenges in China, particularly in the skin health business.
  • Pricing in North America was negative last year, and segment volumes did not benefit as expected in the back half of the year.
  • The pet nutrition category experienced some volatility, with a slowdown in Europe and challenges in maintaining growth momentum.
  • Competitive activity increased in certain markets, such as India and South Africa, leading to heightened promotional spending.
Operator

Good morning. Welcome to today's Colgate-Palmolive 2024 fourth-quarter and year-end earnings conference call. This call is being recorded and is being simulcast live at www.colgatepalmolive.com.

Now, for opening remarks, I'd like to turn this call over to Chief Investor Relations Officer and Executive Vice President, M&A, John Faucher.

John Faucher
Colgate-Palmolive Co - Chief Investor Relations Officer & EVP M&A

Thanks, Betsy. Good morning, and welcome to our fourth quarter and full year 2024 earnings release conference call. This is John Faucher.

Today's conference call will include forward-looking statements. Actual results could differ materially from these statements. Forward-looking statements inherently involve risks and uncertainties and are made on the basis of our views and assumptions at this time. Please refer to our fourth quarter and full year 2024 earnings press release and related prepared materials, and our most recent filings with the SEC,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot